EnLiSense CCM Advances Validation of Real-Time IBD Inflammatory Biomarker Monitoring with Two Recent Peer-Reviewed Longitudinal Studies
EnLiSense’s IBD Aware device offers the first groundbreaking solution for continuous, non-invasive monitoring of inflammatory…